Contents
Download PDF
pdf Download XML
847 Views
300 Downloads
Share this article
Research Article | Volume 2 Issue 2 (July-Dec, 2021)
A Cross Sectional Study to Evaluate the Impact of Malignancy on Breast Density
 ,
Under a Creative Commons license
Open Access
Published
Sept. 10, 2021
Abstract
Background: Mammographic density has been shown to be a strong independent predictor of breast cancer and a causative factor in reducing the sensitivity of mammography. The risk of breast cancer related to changes in breast density over time, including its regression and persistence, remains controversial. The present study was done to evaluate the impact of malignancy on Breast Density. Material & Methods: Present study was conducted in the Department of General Surgery and Radio diagnosis IGMC Shimla from 1st July 2018 to 30 June 2019. A total of 60 were included and evaluated in the present study. These patients were divided into two groups. Group (A) included 30 patients with biopsy proven carcinoma of the breast while Group (B) included 30 patients with benign breast lesions or pain breast. Results: The mean age of patients presenting in Group A was 55.4±10.9 years and the mean age of the patients presenting in Group B was 54±9.84years respectively. In Group A of 30 cancer patients, majority of patients i.e 21patients (70%) had breast density of Type B. In Group B also, majority 20 patients (66.7%) had breast density Type B. In Group A out of 30 cancer patients, 10patients (i.e.33.3%) were BIRADS 4, 14 patients (46.7%) were BIRADS 5 and 6 patients (20%) were BIRADS 6. In Group B out of 30 patients, 6 patients (i.e.20%) were BIRADS 1, 12 patients (40%) were BIRADS 2 and 12 patients (40%) were BIRADS 3. In Group A of 30 cancer patients ,27 patients were diagnosed with duct cell carcinoma (90%) while 2 patient were reported as lobular carcinoma (6.7%) and 1 patients was diagnosed with tubular carcinoma(3.3%) . In Group B out of 30 patients, 2 patients (6.7%) were diagnosed as acute mastitis, 19 patients (63.3%) were diagnosed as Fibro-adenosis, 3patients (10%) were diagnosed as Fibro-adenoma. Conclusion: Maximum patients in this study were in the age group of 40-60year .Most breast cancer patients had higher BIRADS 5&6 , had breast density of Type B and majority of were reported as Duct Cell Carcinoma. Most of the benign breast disease patients had BIRADS2&3, had breast density of Type B and majority of were reported as Fibro-adenosis.
Keywords
Advertisement
Recommended Articles
Research Article
Hyperlipidemia is a Risk Factor for Patients Suffering from Thrombophlebitis: A Finding from an Analytical Cross-Sectional Study Conducted in a Medical College in the Foothills of Western Himalayas
Published: 10/10/2022
Download PDF
Original Article
Role of Audits in Helathcare associated Infections
Published: 20/06/2024
Download PDF
Research Article
Thyroid Health in Shimla: Recognizing and Addressing Common Disorders
...
Published: 29/05/2024
Download PDF
Review Article
Hospital-Acquired Infections: Comprehensive Insights into Epidemiology, Pathophysiology, Risk Factors, Diagnosis, and Treatment
Published: 30/06/2024
Download PDF
Chat on WhatsApp
Flowbite Logo
Najmal Complex,
Opposite Farwaniya,
Kuwait.
Email: kuwait@iarcon.org

Editorial Office:
J.L Bhavan, Near Radison Blu Hotel,
Jalukbari, Guwahati-India
Useful Links
Order Hard Copy
Privacy policy
Terms and Conditions
Refund Policy
Others
About Us
Contact Us
Online Payments
Join as Editor
Join as Reviewer
Subscribe to our Newsletter
Follow us
MOST SEARCHED KEYWORDS
scientific journal
 | 
business journal
 | 
medical journals
 | 
Scientific Journals
 | 
Academic Publisher
 | 
Peer-reviewed Journals
 | 
Open Access Journals
 | 
Impact Factor
 | 
Indexing Services
 | 
Journal Citation Reports
 | 
Publication Process
 | 
Impact factor of journals
 | 
Finding reputable journals for publication
 | 
Submitting a manuscript for publication
 | 
Copyright and licensing of published papers
 | 
Writing an abstract for a research paper
 | 
Manuscript formatting guidelines
 | 
Promoting published research
 | 
Publication in high-impact journals
Copyright © iARCON Internaltional LLP . All Rights Reserved.